Dermata Therapeutics Inc (DRMA)
4.40
-0.80
(-15.38%)
USD |
NASDAQ |
May 17, 16:00
4.40
0.00 (0.00%)
After-Hours: 20:00
Dermata Therapeutics Total Liabilities (Quarterly): 1.624M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 1.624M |
| September 30, 2023 | 0.9168M |
| June 30, 2023 | 0.6829M |
| March 31, 2023 | 1.207M |
| December 31, 2022 | 0.9226M |
| September 30, 2022 | 1.504M |
| June 30, 2022 | 1.366M |
| Date | Value |
|---|---|
| March 31, 2022 | 1.192M |
| December 31, 2021 | 1.517M |
| September 30, 2021 | 1.195M |
| June 30, 2021 | 1.643M |
| March 31, 2021 | 0.9392M |
| December 31, 2020 | 3.783M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
0.6829M
Minimum
Jun 2023
3.783M
Maximum
Dec 2020
1.422M
Average
1.207M
Median
Mar 2023
Total Liabilities (Quarterly) Benchmarks
| GlucoTrack Inc | 1.708M |
| NovaBay Pharmaceuticals Inc | 5.197M |
| Palatin Technologies Inc | 9.827M |
| iBio Inc | 24.82M |
| Theriva Biologics Inc | 14.61M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 7.979M |
| Shareholders Equity (Quarterly) | 6.355M |